Hook
Posted Oct 5, 2026Video · 1:11by @nbcnews
We didn’t find a product being promoted in this video. Its hook, format and structure below still show why it took off.
Browse products winning on TikTokThe video leverages a high-stakes, emotionally resonant medical breakthrough story that provides hope to a large audience, presented with the authority of a major news network.
NBC News reports on a clinical trial for Type 1 diabetes involving islet cell transplants and the anti-rejection drug tegoprubart. The segment features a patient who has seen positive results and a medical expert who discusses the potential of this and other emerging treatments.
Katie Beth Hand was one of several people with Type 1 diabetes who were able to go off insulin after participating in a small clinical trial. Patients in the trial received an experimental drug designed to prevent transplant rejection with fewer side effects, but all of the experts who spoke to NBC News cautioned that much more research is needed — in a larger group of patients and carried out over a longer period of time.
Could a breakthrough new treatment cure Type 1 diabetes?
Introduction to the clinical trial patient
Explanation of the islet cell transplant process
Introduction of the drug tegoprubart
Expert commentary on the trial results
Patient perspective on life after treatment
NBC News (a) appears as a watermark and in the reporter's title, (b) appears as the source of the news report. Removing it would not change the content of the medical report. Mount Sinai Hospital (a) appears as a logo on a lab coat, (b) appears as the affiliation of the expert. Removing it would not change the content. Tegoprubart (a) acts as the specific drug being discussed as part of the clinical trial. It is the subject of the medical report. Removing it would change the medical content of the video.

Outliers and viral hits: their videos on Overshot, all time.